Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Plausible Mechanism Draft Guidance
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities
-
ACMG Response to RFI on NIH Genomic Data Sharing Policy
-
Understanding the Details: ACMG’s Position on the Access to Genetic Counselor Services Act
-
ACMG Letter Regarding Arizona House Bill 2815 (2021) – Support with Amendments
-
ACMG Letter Regarding Rhode Island House Bill 5147 (2021) – Support with Amendments
-
ACMG Letter Regarding Rhode Island Senate Bill 111 (2021) – Support with Amendments
-
ACMG Letter Regarding New York Assembly Bill 2151 (2021) – Support with Amendments
-
ACMG Letter Regarding Oregon House Bill 2619 (2021) – Support